Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ipilimumab in the treatment of metastatic melanoma: management of adverse events.

Ipilimumab in the treatment of metastatic melanoma: management of adverse events. Onco Targets Ther. 2014; 7:203-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.